WFH 2025: Elevating Levels of Endogenous Circulating von Willebrand Factor (VWF) The Potential of HMB-002 as Prophylactic Treatment of von Willebrand Disease (VWD)
Presented at WFH 2025 Comprehensive Care Summit: New Developments in Bleeding Disorders and MSK
To view the presentation, click here